Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HIGHLY POTENT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 368 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Cowell, SM; Balse-Srinivasan, PM; Ahn, JM; Hruby, VJ
      Design and synthesis of peptide antagonists and inverse agonists for G protein-coupled receptors

      G PROTEIN PATHWAYS, PT A, RECEPTORS
    2. Matziari, M; Georgiadis, D; Dive, V; Yiotakis, A
      Convenient synthesis and diversification of dehydroalaninyl phosphinic peptide analogues

      ORGANIC LETTERS
    3. Lung, FDT; Lang, YQ; King, CR; Varady, J; Wu, XW; Wang, S; Roller, PP
      Functional preference of the constituent amino acid residues in a phage-library-based nonphosphorylated inhibitor of the Grb2-SH2 domain

      JOURNAL OF PEPTIDE RESEARCH
    4. Miller, MD; Hazuda, DJ
      New antiretroviral agents: looking beyond protease and reverse transcriptase

      CURRENT OPINION IN MICROBIOLOGY
    5. Herrera, VLM; Ruiz-Opazo, N
      Identification of a novel V1-type AVP receptor based on the molecular recognition theory

      MOLECULAR MEDICINE
    6. Liu, S; Edwards, DS
      Stabilization of Y-90-labeled DOTA-biomolecule conjugates using gentisic acid and ascorbic acid

      BIOCONJUGATE CHEMISTRY
    7. Agrawal, VK; Khadikar, PV
      QSAR studies on acylated histamine derivatives

      BIOORGANIC & MEDICINAL CHEMISTRY
    8. Stutzmann, JM; Bohme, GA; Boireau, A; Damour, D; Debono, MW; Genevois-Borella, A; Jimonet, P; Pratt, J; Randle, JCR; Ribeill, Y; Vuilhorgne, M; Mignani, S
      Synthesis of anticonvulsive AMPA antagonists: 4-oxo-10-substituted-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    9. Savini, L; Campiani, G; Gaeta, A; Pellerano, C; Fattorusso, C; Chiasserini, L; Fedorko, JM; Saxena, A
      Novel and potent tacrine-related hetero- and homobivalent ligands for acetylcholinesterase and butyrylcholinesterase

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    10. Pouzet, B; Serradeil-Le Gal, C; Bouby, N; Maffrand, JP; Le Fur, G; Bankir, L
      Selective blockade of vasopressin V-2 receptors reveals significant V-2-mediated water reabsorption in Brattleboro rats with diabetes insipidus

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    11. Garcia-Echeverria, C
      Antagonists of the Src homology 2 (SH2) domains of Grb2, Src, Lck and ZAP-70

      CURRENT MEDICINAL CHEMISTRY
    12. De Clercq, E
      Hamao Umezawa Memorial Award lecture 'an odyssey in the viral chemotherapyfield'

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    13. Sorbera, LA; Rabasseda, X; Silvestre, J; Castaner, J
      Vilazodone hydrochloride - Antidepressant - 5-HT1A partial agonist - 5-HT reuptake inhibitor

      DRUGS OF THE FUTURE
    14. Sasse, A; Ligneau, X; Sadek, B; Elz, S; Pertz, HH; Ganellin, CR; Arrang, JM; Schwartz, JC; Schunack, W; Stark, H
      Benzophenone derivatives and related compounds as potent histamine H-3-receptor antagonists and potential PET/SPECT ligands

      ARCHIV DER PHARMAZIE
    15. Noble, F; Banisadr, G; Jardinaud, F; Popovici, T; Lai-Kuen, R; Chen, H; Bischoff, L; Parsadaniantz, SM; Fournie-Zaluski, MC; Roques, BP
      First discrete autoradiographic distribution of aminopeptidase N in various structures of rat brain and spinal cord using the selective iodinated inhibitor [I-125]RB 129

      NEUROSCIENCE
    16. Baraldi, PG; Cacciari, B; Romagnoli, R; Klotz, KN; Spalluto, G; Varani, K; Gessi, S; Merighi, S; Borea, PA
      Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor ligands: A starting point for searching A(2B) adenosine receptor antagonists

      DRUG DEVELOPMENT RESEARCH
    17. Aleksic, S; Szabo, Z; Scheffel, U; Ravert, HT; Mathews, WB; Kerenyi, L; Rauseo, PA; Gibson, RE; Burns, HD; Dannals, RF
      In vivo labeling of endothelin receptors with [C-11]L-753,037: Studies in mice and a dog

      JOURNAL OF NUCLEAR MEDICINE
    18. Haubner, R; Wester, HJ; Burkhart, F; Senekowitsch-Schmidtke, R; Weber, W; Goodman, SL; Kessler, H; Schwaiger, M
      Glycosylated RGD-containing peptides, tracer for tumor targeting and angiogenesis imaging with improved biokinetics

      JOURNAL OF NUCLEAR MEDICINE
    19. Miller, CP; Komm, BS
      Chapter 15. Targeting the estrogen receptor with SERMs

      ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 36
    20. Tremblay, MR; Lin, SX; Poirier, D
      Chemical synthesis of 16 beta-propylaminoacyl derivatives of estradiol andtheir inhibitory potency on type 1 17 beta-hydroxy steroid dehydrogenase and binding affinity on steroid receptors

      STEROIDS
    21. Datta, PK; Moulder, JE; Fish, BL; Cohen, EP; Lianos, EA
      Induction of heme oxygenase 1 in radiation nephropathy: Role of angiotensin II

      RADIATION RESEARCH
    22. Silver, RB; Mackins, CJ; Smith, NCE; Koritchneva, IL; Lefkowitz, K; Lovenberg, TW; Levi, R
      Coupling of histamine H-3 receptors to neuronal Na+/H+ exchange: A novel protective mechanism in myocardial ischemia

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    23. Pontow, S; Ratner, L
      Evidence for common structural determinants of human immunodeficiency virus type 1 coreceptor activity provided through functional analysis of CCR5/CXCR4 chimeric coreceptors

      JOURNAL OF VIROLOGY
    24. Ambo, A; Hamazaki, N; Yamada, Y; Nakata, E; Sasaki, Y
      Structure-activity studies on nociceptin analogues: ORL1 receptor binding and biological activity of cyclic disulfide-containing analogues of nociceptin peptides

      JOURNAL OF MEDICINAL CHEMISTRY
    25. Baraldi, PG; Cacciari, B; Moro, S; Romagnoli, R; Ji, XD; Jacobson, KA; Gessi, S; Borea, PA; Spalluto, G
      Fluorosulfonyl- and bis-(beta-chloroethyl)amino-phenylamino functionalizedpyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: Irreversible antagonists at the human A(3) adenosine receptor and molecular modeling studies

      JOURNAL OF MEDICINAL CHEMISTRY
    26. Maeda, K; Yoshimura, K; Shibayama, S; Habashita, H; Tada, H; Sagawa, K; Miyakawa, T; Aoki, M; Fukushima, D; Mitsuya, H
      Novel low molecular weight spirodiketopiperazine derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5

      JOURNAL OF BIOLOGICAL CHEMISTRY
    27. Gerlach, LO; Skerlj, RT; Bridger, GJ; Schwartz, TW
      Molecular interactions of cyclam and bicyclam non-peptide antagonists withthe CXCR4 chemokine receptor

      JOURNAL OF BIOLOGICAL CHEMISTRY
    28. Ros, E; Aleu, J; de Aranda, IG; Munoz-Torrero, D; Camps, P; Badia, A; Marsal, J; Solsona, C
      The pharmacology of novel acetylcholinesterase inhibitors, (+/-)-huprines Y and X, on the Torpedo electric organ

      EUROPEAN JOURNAL OF PHARMACOLOGY
    29. Yu, YX; Kawarai, M; Koss, MC
      Histamine H-3 receptor-mediated inhibition of sympathetically evoked mydriasis in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    30. Tsukada, J; Tahara, A; Tomura, Y; Wada, K; Kusayama, T; Ishii, N; Yatsu, T; Uchida, W; Taniguchi, N; Tanaka, A
      Effects of YM471, a nonpeptide AVP V-1A and V-2 receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cells

      BRITISH JOURNAL OF PHARMACOLOGY
    31. Iwasaki, T; Hayasaki-Kajiwara, Y; Matsuo, Y; Nakajima, M
      Endothelin receptor antagonist activity of (R)-(-)-2-(benzo[1,3]dioxol-5-yl)-N-(4-isopropylphenylsulfonyl)-2-(6-methyl-2-propylpyridin-3-yloxy) acetamide hydrochloride (PABSA) in rat aortic smooth muscle cells and isolated rat thoracic aorta

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    32. Hruby, VJ
      Design in topographical space of peptide and peptidomimetic ligands that affect behavior. A chemist's glimpse at the mind-body problem

      ACCOUNTS OF CHEMICAL RESEARCH
    33. Phan, LT; Clark, RF; Rupp, M; Or, YS; Chu, DTW; Ma, Z
      Synthesis of 2-fluoro-6-O-propargyl-11,15-carbamate ketolides. A novel class of antibiotics

      ORGANIC LETTERS
    34. Verdier, L; Gharbi-Benarous, J; Bertho, G; Evrard-Todeschi, N; Mauvais, P; Girault, JP
      Dissociation-equilibrium constant and bound conformation for weak antibiotic binding interaction with different bacterial ribosomes

      JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2
    35. Fretz, H; Furet, P; Garcia-Echeverria, C; Rahuel, J; Schoepfer, J
      Structure-based design of compounds inhibiting Grb2-SH2 mediated protein-protein interactions in signal transduction pathways

      CURRENT PHARMACEUTICAL DESIGN
    36. Blair, WS; Lin, PF; Meanwell, NA; Wallace, OB
      HIV-1 entry - an expanding portal for drug discovery

      DRUG DISCOVERY TODAY
    37. Tozer, MJ; Kalindjian, SB
      Histamine H-3 receptor antagonists

      EXPERT OPINION ON THERAPEUTIC PATENTS
    38. Turpin, JA; Howard, OMZ
      Inhibitors of HIV cellular fusion

      EXPERT OPINION ON THERAPEUTIC PATENTS
    39. Guillou, C; Mary, A; Renko, DZ; Gras, E; Thal, C
      Potent acetylcholinesterase inhibitors: Design, synthesis and structure-activity relationships of alkylene linked bis-galanthamine and galanthamine-galanthaminium salts

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    40. Denis, A; Bretin, F; Fromentin, C; Bonnet, A; Piltan, G; Bonnefoy, A; Agouridas, C
      beta-keto-ester chemistry and ketolides. Synthesis and antibacterial activity of 2-halogeno, 2-methyl and 2,3 enol-ether ketolides

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    41. Chan, WY; Wo, NC; Stoev, S; Cheng, LL; Manning, M
      Discovery and design of novel and selective vasopressin and oxytocin agonists and antagonists: the role of bioassays

      EXPERIMENTAL PHYSIOLOGY
    42. Costi, R; Di Santo, R; Artico, M; Massa, S; Lavecchia, A; Marceddu, T; Sanna, L; La Colla, P; Marongiu, ME
      Structure-activity relationship studies on potential non-nucleoside DABO-like inhibitors of HIV-1 reverse transcriptase

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    43. Mallion, JM; Baguet, JP
      Putting the efficacy of candesartan cilexetil into perspective: a review of new comparative data

      JOURNAL OF HUMAN HYPERTENSION
    44. Naito, A; Ohtake, Y; Hasegawa, H; Fukaya, Y; Kurasawa, T; Naito, K; Matsukawa, H; Oguma, T; Ezure, Y; Tsuriya, Y; Tanaka, H; Koike, K; Shigenobu, K
      Pharmacological profile of VP-343, a novel selective vasopressin V-2 receptor antagonist, in rats

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    45. Matsubara, S; Saito, K; Kizawa, Y; Sano, M; Osawa, M; Iwamoto, K; Murakami, H
      Evidence for the AT(1) subtype of the angiotensin II receptor in the rat submandibular gland

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    46. Kozawa, O; Kawamura, H; Hatakeyama, D; Matsuno, H; Uematsu, T
      Endothelin-1 induces vascular endothelial growth factor synthesis in osteoblasts - Involvement of p38 mitogen-activated protein kinase

      CELLULAR SIGNALLING
    47. Fabiani, ME; Dinh, DT; Nassis, L; Casley, DJ; Johnston, CI
      In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: A comparison with losartan

      AMERICAN JOURNAL OF HYPERTENSION
    48. Vanderheyden, PML; Verheijen, I; Fierens, FLP; DeBacker, JP; Vauquelin, G
      Inhibition of angiotensin II-induced inositol phosphate production by triacid nonpeptide antagonists in CHO cells expressing human AT(1) receptors

      PHARMACEUTICAL RESEARCH
    49. De Clercq, E
      Structures and activities of non-nucleoside reverse transcriptase inhibitors (NNRTIs).

      MEDECINE ET MALADIES INFECTIEUSES
    50. Norman, P; Leeson, PA; Rabasseda, X; Castaner, J; Castaner, RM
      Conivaptan hydrochloride. Treatment of heart failure, Treatment of hyponatremia, Vasopressin V-1a/V-2 antagonist.

      DRUGS OF THE FUTURE
    51. Radl, S; Hafner, W; Budesinsky, M; Hejnova, L; Krejci, I
      Synthesis, analgesic activity, and binding properties of some epibatidine analogs with a tropine skeleton

      ARCHIV DER PHARMAZIE
    52. Opgenorth, TJ; Wessale, JL; Dixon, DB; Adler, AL; Calzadilla, SV; Padley, RJ; Wu-Wong, JR
      Effects of endothelin receptor antagonists on the plasma immunoreactive endothelin-1 level

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    53. Rastogi, N; Goh, KS; Berchel, M; Bryskier, A
      In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004compared to those of clarithromycin against slowly growing mycobacteria atpHs 6.8 and 7.4

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    54. Liu, G
      Recent advances in endothelin antagonism

      ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35
    55. Naka, T; Kubo, K; Nishikawa, K; Inada, Y; Furukawa, Y
      Angiotensin II receptor antagonists: Candesartan cilexetil

      YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
    56. Rusconi, S; Catamancio, SL; Citterio, P; Bulgheroni, E; Croce, F; Herrmann, SH; Offord, RE; Galli, M; Hirsch, MS
      Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: In vitro studies of mixed virus infections

      JOURNAL OF VIROLOGY
    57. Jimenez, W; Serradeil-Le Gal, C; Ros, J; Cano, C; Cejudo, P; Morales-Ruiz, M; Arroyo, V; Pascal, M; Rivera, F; Maffrand, JP; Rodes, J
      Long-term aquaretic efficacy of a selective nonpeptide V-2-vasopressin receptor antagonist, SR121463, in cirrhotic rats

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    58. Rouleau, A; Stark, H; Schunack, W; Schwartz, JC
      Anti-inflammatory and antinociceptive properties of BP 2-94, a histamine H-3-receptor agonist prodrug

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    59. Chen, HX; Noble, F; Mothe, A; Meudal, H; Coric, P; Danascimento, S; Roques, BP; George, P; Fournie-Zaluski, MC
      Phosphinic derivatives as new dual enkephalin-degrading enzyme inhibitors:Synthesis, biological properties, and antinociceptive activities

      JOURNAL OF MEDICINAL CHEMISTRY
    60. Rivier, JE; Struthers, RS; Porter, J; Lahrichi, SL; Jiang, GC; Cervini, LA; Ibea, M; Kirby, DA; Koerber, SC; Rivier, CL
      Design of potent dicyclic (4-10/5-8) gonadotropin releasing hormone (GnRH)antagonists

      JOURNAL OF MEDICINAL CHEMISTRY
    61. Rivier, JE; Porter, J; Cervini, LA; Lahrichi, SL; Kirby, DA; Struthers, RS; Koerber, SC; Rivier, CL
      Design of monocyclic (1-3) and dicyclic (1-3/4-10) gonadotropin releasing hormone (GnRH) antagonists

      JOURNAL OF MEDICINAL CHEMISTRY
    62. Rivier, JE; Jiang, GC; Struthers, RS; Koerber, SC; Porter, J; Cervini, LA; Kirby, DA; Craig, AG; Rivier, CL
      Design of potent dicyclic (1-5/4-10) gonadotropin releasing hormone (GnRH)antagonists

      JOURNAL OF MEDICINAL CHEMISTRY
    63. Koerber, SC; Rizo, J; Struthers, RS; Rivier, JE
      Consensus bioactive conformation of cyclic GnRH antagonists defined by NMRand molecular modeling

      JOURNAL OF MEDICINAL CHEMISTRY
    64. Guzikowski, AP; Tamiz, AP; Acosta-Burruel, M; Hong-Bae, S; Cai, SX; Hawkinson, JE; Keana, JFW; Kesten, SR; Shipp, CT; Tran, M; Whittemore, ER; Woodward, RM; Wright, JL; Zhou, ZL
      Synthesis of N-substituted 4-(4-hydroxyphenyl)piperidines, 4-(4-hydroxybenzyl)piperidines, and (+/-)-3-(4-hydroxyphenyl)pyrrolidines: Selective antagonists at the 1A/2B NMDA receptor subtype

      JOURNAL OF MEDICINAL CHEMISTRY
    65. Schiller, PW; Berezowska, I; Nguyen, TMD; Schmidt, R; Lemieux, C; Chung, NN; Falcone-Hindley, ML; Yao, WQ; Liu, J; Iwama, S; Smith, AB; Hirschmann, R
      Novel ligands lacking a positive charge for the delta- and mu-opioid receptors

      JOURNAL OF MEDICINAL CHEMISTRY
    66. Bonner, GG; Davis, P; Stropova, D; Edsall, S; Yamamura, HI; Porreca, F; Hruby, VJ
      Opiate aromatic pharmacophore structure-activity relationships in CTAP analogues determined by topographical bias, two-dimensional NMR, and biological activity assays

      JOURNAL OF MEDICINAL CHEMISTRY
    67. Stark, H; Sadek, B; Krause, M; Huls, A; Ligneau, X; Ganellin, CR; Arrang, JM; Schwartz, JC; Schunack, W
      Novel histamine H-3-receptor antagonists with carbonyl-substituted 4-(3-(phenoxy)propyl)-1H-imidazole structures like ciproxifan and related compounds

      JOURNAL OF MEDICINAL CHEMISTRY
    68. Hiyoshi, H; Yanagimachi, M; Ito, M; Ohtsuka, I; Yoshida, I; Saeki, T; Tanaka, H
      Effect of ER-27856, a novel squalene synthase inhibitor, on plasma cholesterol in rhesus monkeys: comparison with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors

      JOURNAL OF LIPID RESEARCH
    69. Klein, ES; Wang, JW; Khalifa, B; Gavigan, SA; Chandraratna, RAS
      Recruitment of nuclear receptor corepressor and coactivator to the retinoic acid receptor by retinoid ligands - Influence of DNA-heterodimer interactions

      JOURNAL OF BIOLOGICAL CHEMISTRY
    70. Cotte, N; Balestre, MN; Aumelas, A; Mahe, E; Phalipou, S; Morin, D; Hibert, M; Manning, M; Durroux, T; Barberis, C; Mouillac, B
      Conserved aromatic residues in the transmembrane region VI of the V-1a vasopressin receptor differentiate agonist vs. antagonist ligand binding

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    71. Tamura, T; Said, S; Harris, J; Lu, WY; Gerdes, AM
      Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system

      CIRCULATION
    72. Nakamura, S; Yamamura, Y; Itoh, S; Hirano, T; Tsujimae, K; Aoyama, M; Kondo, K; Ogawa, H; Shinohara, T; Kan, K; Tanada, Y; Teramoto, S; Sumida, T; Nakayama, S; Sekiguchi, K; Kambe, T; Tsujimoto, G; Mori, T; Tominaga, M
      Characterization of a novel nonpeptide vasopressin V-2-agonist, OPC-51803,in cells transfected human vasopressin receptor subtypes

      BRITISH JOURNAL OF PHARMACOLOGY
    73. Piovezan, AP; D'Orleans-Juste, P; Souza, GEP; Rae, GA
      Endothelin-1-induced ETA receptor-mediated nociception, hyperalgesia and oedema in the mouse hind-paw: modulation by simultaneous ETB receptor activation

      BRITISH JOURNAL OF PHARMACOLOGY
    74. Tahara, A; Tsukada, J; Tomura, Y; Wada, K; Kusayama, T; Ishii, N; Yatsu, T; Uchida, W; Tanaka, A
      Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cells

      BRITISH JOURNAL OF PHARMACOLOGY
    75. Stavrakoudis, A; Bizos, G; Eleftheriadis, D; Kouki, A; Panou-Pomonis, E; Sakarellos-Daitsiotis, M; Sakarellos, C; Tsoukatos, D; Tsikaris, V
      A three-residue cyclic scaffold of non-RGD containing peptide analogues asplatelet aggregation inhibitors: Design, synthesis, and structure-functionrelationships

      BIOPOLYMERS
    76. Mao, C; Sudbeck, EA; Venkatachalam, TK; Uckun, FM
      Structure-based drug design of non-nucleoside inhibitors for wild-type anddrug-resistant: HIV reverse transcriptase

      BIOCHEMICAL PHARMACOLOGY
    77. Vanderheyden, PML; Fierens, FLP; De Backer, JP; Vauquelin, G
      Reversible and syntopic interaction between angiotensin receptor antagonists on Chinese hamster ovary cells expressing human angiotensin II type I receptors

      BIOCHEMICAL PHARMACOLOGY
    78. Tsuji, M; Takeda, H; Matsumiya, T
      Different effects of 5-HT1A receptor agonists and benzodiazepine anxiolytics on the emotional state of naive and stressed mice: a study using the hole-board test

      PSYCHOPHARMACOLOGY
    79. Schmeck, J; Gluth, H; Mihaljevic, N; Born, M; Wendel-Wellner, M; Krafft, P
      ET-1-induced pulmonary vasoconstriction shifts from ETA- to ETB-receptor-mediated reaction after preconstriction

      JOURNAL OF APPLIED PHYSIOLOGY
    80. Naka, T; Kubo, K
      A new class of diacidic nonpeptide angiotensin II receptor antagonists: Candesartan cilexetil

      CURRENT PHARMACEUTICAL DESIGN
    81. Schiller, PW; Weltrowska, G; Schmidt, R; Berezowska, I; Nguyen, TMD; Lemieux, C; Chung, NN; Carpenter, KA; Wilkes, BC
      Subtleties of structure-agonist versus antagonist relationships of opioid peptides and peptidomimetics

      JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH
    82. Manning, M; Stoev, S; Cheng, LL; Wo, NC; Chan, WY
      Synthesis and structure-activity investigation of novel vasopressin hypotensive peptide agonists

      JOURNAL OF PEPTIDE SCIENCE
    83. Locardi, E; Mullen, DG; Mattern, RH; Goodman, M
      Conformations and pharmacophores of cyclic RGD containing peptides which selectively bind integrin alpha(v)beta(3)

      JOURNAL OF PEPTIDE SCIENCE
    84. Ruan, XP; Purdy, KE; Oliverio, MI; Coffman, TM; Arendshorst, WJ
      Effects of candesartan on angiotensin II-induced renal vasoconstriction inrats and mice

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    85. Morsing, P
      Candesartan: A new-generation angiotensin II AT(1) receptor blocker: Pharmacology, antihypertensive efficacy, renal function, and renoprotection

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    86. Gibson, RE; Fioravanti, C; Francis, B; Burns, HD
      Radioiodinated endothelin-1: A radiotracer for imaging endothelin receptordistribution and occupancy

      NUCLEAR MEDICINE AND BIOLOGY
    87. Hajela, K; Pandey, J; Dwivedy, A; Dhar, JD; Sarkhel, S; Maulik, PR; Velumurugan, D
      Resolution, molecular structure and biological activities of the D- and L-enantiomers of potent anti-implantation agent, DL-2-[4-(2-piperidinoethoxy)phenyl]-3-phenyl-2H-1-benzopyran

      BIOORGANIC & MEDICINAL CHEMISTRY
    88. Tremblay, MR; Luu-The, V; Leblanc, G; Noel, P; Breton, E; Labrie, F; Poirier, D
      Spironolactone-related inhibitors of type II 17 beta-hydroxysteroid dehydrogenase: Chemical synthesis, receptor binding affinities, and proliferativeantiproliferative activities

      BIOORGANIC & MEDICINAL CHEMISTRY
    89. Carlier, PR; Han, YF; Chow, ESH; Li, CPL; Wang, H; Lieu, TX; Wong, HS; Pang, YP
      Evaluation of short-tether bis-THA AChE inhibitors. A further test of the dual binding site hypothesis

      BIOORGANIC & MEDICINAL CHEMISTRY
    90. Schmid, CR; Glasebrook, AL; Misner, JW; Stephenson, GA
      Synthesis and biological activity of trans-2,3-dihydroraloxifene

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    91. Vuligonda, V; Standeven, AM; Escobar, M; Chandraratna, RAS
      A new class of potent RAR antagonists: Dihydroanthracenyl, benzochromenyl and benzothiochromenyl retinoids

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    92. Tremblay, MR; Simard, J; Poirier, D
      Parallel solid-phase synthesis of a model library of 7 alpha-alkylamide estradiol derivatives as potential estrogen receptor antagonists

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    93. Fujiwara, M; Kodama, EN; Okamoto, M; Tokuhisa, K; Ide, T; Hanasaki, Y; Katsuura, K; Takayama, H; Aimi, N; Mitsuya, H; Shigeta, S; Konno, K; Yokota, T; Baba, M
      Characterization of human immunodeficiency virus type 1 strains resistant to the non-nucleoside reverse transcriptase inhibitor RD4-2217

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    94. Taylor, DL; Ahmed, PS; Chambers, P; Tyms, AS; Bedard, J; Duchaine, J; Falardeau, G; Lavallee, JF; Brown, W; Rando, RF; Bowlin, T
      Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    95. Datta, PK; Moulder, JE; Fish, BL; Cohen, EP; Lianos, EA
      TGF-beta 1 production in radiation nephropathy: role of angiotensin II

      INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    96. Inada, Y; Ojima, M; Kanagawa, R; Misumi, Y; Nishikawa, K; Naka, T
      Pharmacologic properties of candesartan cilexetil - possible mechanisms oflong-acting antihypertensive action

      JOURNAL OF HUMAN HYPERTENSION
    97. de Tullio, P; Delarge, J; Pirotte, B
      Recent advances in the chemistry of cholecystokinin receptor ligands (agonists and antagonists)

      CURRENT MEDICINAL CHEMISTRY
    98. Hempelmann, RG; Pradel, RHE; Mehdorn, HM; Ziegler, A
      Threshold concentrations of endothelin-1: The effects on contractions induced by 5-hydroxytryptamine in isolated rat cerebral and mesenteric arteries

      PHARMACOLOGY & TOXICOLOGY
    99. Barber, A; Bender, HM; Gottschlich, R; Greiner, HE; Harting, J; Mauler, F; Seyfried, CA
      Effects of GR-89696 and the novel peripherally selective OP2 agonists, EMD-61569 and EMD-61747, against focal cerebral ischemia in the rat

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    100. Woo, PWK; Hartman, J; Huang, Y; Nanninga, T; Bauman, K; Butler, DE; Rubin, JR; Lee, HT; Huang, CC
      Atorvastatin, an HMG-CoA reductase inhibitor and efficient lipid-regulating agent. Part I. Synthesis of ring-labeled [C-14]atorvastatin.

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 13:26:20